The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials

We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2+ early breast cancer enrolled in the WSG-ADAPT subtrials.

Gespeichert in:
Autor*in:

Graeser, Monika [verfasserIn]

Harbeck, Nadia

Gluz, Oleg

Würstlein, Rachel

zu Eulenburg, Christine

Schumacher, Claudia

Grischke, Eva-Maria

Forstbauer, Helmut

Dimpfl, Moritz

Braun, Michael

Christgen, Matthias

Kreipe, Hans Heinrich

Potenberg, Jochem

von Schumann, Raquel

Aktas, Bahriye

Kolberg-Liedtke, Cornelia

Kümmel, Sherko

Nitz, Ulrike

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2021

Schlagwörter:

Neoadjuvant therapy

Ultrasonography

Pathologic complete response

Breast neoplasm

Umfang:

9

Übergeordnetes Werk:

Enthalten in: The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study - Yang, Lin ELSEVIER, 2020, Amsterdam [u.a.]

Übergeordnetes Werk:

volume:59 ; year:2021 ; pages:58-66 ; extent:9

Links:

Volltext

DOI / URN:

10.1016/j.breast.2021.06.001

Katalog-ID:

ELV055235212

Nicht das Richtige dabei?

Schreiben Sie uns!